Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03477318 · ClinicalTrials.gov registry record
Accuracy of Endoscopists in Predicting Polyp Pathology
A clinical trial of Resected Polyp, sponsored by TriHealth.
- Completed
- Registry status
- 159
- Enrollment target
- 1
- Study location
NCT03477318: Completed study of Resected Polyp, sponsored by TriHealth.
NCT03477318 is a study of Resected Polyp that has completed, run by TriHealth. The registered enrollment target is 159 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03477318, a study of Resected Polyp, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 159 participants
- Enrollment target
- 1
- Study location
Study Summary
The study purpose is to assess the accuracy of experienced endoscopists at a community hospital in predicting histological types of polyps resected at colonoscopy using white light. Patients 50 years or older undergoing first-time screening colonoscopy will be included in this observational study.
Primary Outcome
Accuracy of predicting polyp type
Conditions Studied
Study Locations (1)
Ohio
- Good Samaritan Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2018-03-20 |
| Est. Completion | 2018-11-07 |
What the finished NCT03477318 record still lists
NCT03477318 is an observational study that tracks outcomes without assigning an intervention. The registered 159 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Resected Polyp appearing as the primary indexed condition, and to 0 interventions.
NCT03477318 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03477318 about?
NCT03477318 is a clinical study titled "Accuracy of Endoscopists in Predicting Polyp Pathology". The study purpose is to assess the accuracy of experienced endoscopists at a community hospital in predicting histological types of polyps resected at colonoscopy using white light. Patients 50 years or older undergoing first-time screening colonoscopy will be included in this observational study.
What is the current status of trial NCT03477318?
This trial is currently completed. The enrollment target is 159 participants. The study started on 2018-03-20. Estimated completion is 2018-11-07.
What conditions does trial NCT03477318 study?
This clinical trial studies the following conditions: Resected Polyp.
Who is sponsoring clinical trial NCT03477318?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03477318 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267626 · 159 participants · Phase 1
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- NCT06321575 · 159 participants · NA
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- NCT06729151 · 159 participants
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
- NCT07023731 · 159 participants · Phase 1
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI